Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics
 

 

Mid-Atlantic Node


The Mid-Atlantic Node includes Johns Hopkins University School of Medicine, Virginia Commonwealth University, Friends Research Institute, and seven CTPs. The CTP network provides about 5,000 treatment slots serving a diverse group of people suffering from substance use disorder, which is often complicated by other psychiatric and medical illnesses.

 

Regional Research and Training Center

The Johns Hopkins University
Research Foundation for Mental
School of Medicine
720 Rutland Avenue
Baltimore, MD 21205-2196


Principal Investigator

Maxine Stitzer, Ph.D.
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Suite 1500
Baltimore, MD 21224-6823
410-550-0042 (Voice)
mstitzer@mail.jhmi.edu



Community Treatment Programs

Chesterfield CSB Substance Abuse Service
Chesterfield, VA

DayBreak Rehabilitation Program
Baltimore, MD

Glenwood Life Counseling Center
Baltimore, MD

HARBEL Prevention and Recovery Center
Baltimore, MD

Man Alive
Baltimore, MD

Mountain Manor Treatment Programs
Baltimore, MD

Norfolk CSB Substance Abuse Service
Norfolk, VA

REACH Mobile Health Services
Catonsville, MD


Mid-Atlantic Protocol Involvement
PROTOCOL0003 Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules
PROTOCOL0005 Motivational Interviewing (MI)
PROTOCOL0006 Motivational Incentives - Drug Free Clinics
PROTOCOL0007 Motivational Incentives - Methadone Clinics
PROTOCOL0008 A Baseline for Investigating Diffusion of Innovation
PROTOCOL0010 Buprenorphine/Naloxone-Facilitated Rehabilitation for Heroin Addicted Adolescents/Young Adults
PROTOCOL0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Programs
PROTOCOL0020 Job-Seekers Training for Patients with Drug Dependence
PROTOCOL0028 Randomized Controlled Trial of Osmotic-Release Methylphenidate (OROS MPH) for Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents with Substance Use Disorders (SUD)
PROTOCOL0032 HIV Rapid Testing and Counseling in Drug Abuse Treatment Programs in the U.S.



 

 



NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version


National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Monday, July 14, 2008. The U.S. government's official web portal